The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

ResMed

  • RMD
  • NYSE
  • Consumer Products
  • Latest 49.32
  • Currency US$
  • Change -0.27
  • Percent Change -0.544 %
  • Volume 257,195
  • Fri Jul 11, 2014 01:29 PM EDT NYSE data delayed 15 minutes.
Average recommendation
10 Analysts Reporting (Jul 10, 2014)
Strong Buy
Buy
Hold
Underperform
Sell
Change over time
Analyst rating breakdown
  Latest 4 weeks ago 2 months ago 3 months ago Last Year
Strong Buy 4 4 4 5 3
Buy 0 0 0 0 1
Hold 5 5 6 6 6
Underperform 0 0 0 0 0
Sell 1 1 0 0 0

As of Fri Jul 11, 2014 1:45 PM EDT
The consensus recommendation is the average buy, sell or hold rating for a company, based on a survey of brokerage equity analysts by Zacks Investment Research. We update the ratings daily.

Earnings & Estimates

Short Term
    Q3/12 Q4/12 Q1/13 Q2/13 Q3/13 Q4/13 Q1/14 Q2/14 Q4/14 Q1/15  

Actual quarterly earnings for the past eight quarters and estimated for the next two quarters

Estimated EPS ($)   0.41 0.48 0.46 0.51 0.57 0.61 0.57 0.63 0.65 0.61  
Actual EPS   0.46 0.54 0.49 0.53 0.59 0.62 0.56 0.60 -- --  
Surprise (%)   12.2 12.5 6.5 3.9 3.5 1.6 -1.8 -4.8 -- --  
Est. % Chg from Prior Year   0.3 0.4 0.5 0.3 0.3 0.1 0.1 0.1 5.6 8.5  
{#} Analysts   9 9 8 7 4 5 6 4 4 4  
Date of Earnings   Apr 26 Aug 02 Oct 25 Jan 24 Apr 25 Aug 01 Oct 24 Jan 23 Jul 31 Oct 23  

Data provided by Zacks Investment Research.

Long Term
    2014 2015  

Estimated annual earnings for the next
two years

Estimated EPS ($)   2.48 2.68  
Actual EPS   2.22 2.48  
Surprise (%)   -- --  
Est. % Chg from Prior Year   11.9 8.0  
{#} Analysts   6 6  
Date of Earnings   -- --  

Trends & Revisions

Earnings Per Share Trend
  Current 7-Days Ago 30-Days Ago 60-Days Ago 90-Days Ago
  Mean Mean Mean Mean Mean
Current Quarter (ends Jun 2014) 0.65 0.65 0.65 0.65 0.68
Next Quarter (ends Sep 2014) 0.61 0.61 0.61 0.61 0.62
Current Fiscal Year (ends Jun 2014) 2.48 2.48 2.48 2.48 2.51
Next Fiscal Year (ends Jun 2015) 2.68 2.68 2.68 2.70 2.73

Data provided by Zacks Investment Research.

Earnings Revisions
Last 7 Days Last 30 Days
Up Revs Down Revs Up Revs Down Revs
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0